Navigation Links
Vestiage CEO Comments on Immortal Life
Date:4/8/2013

Newport Beach, California (PRWEB) April 08, 2013

Scott Kimball, CEO of Vestiage Inc, a leading publily traded anti-aging company focused on science-based, highly effective cosmeceuticals and nutraceuticals, commented today on the astonishing work surrounding “immortal life” research being done surrounding the “Benjamin Button Jellyfish” and Stem Cells.

Kimball stated, “Because of what is occurring in Human Stem Cell laboratories all over the US, it is no longer absurd to start thinking in terms of life expectancies for our children to be 150 years old. As part of our research and product development effort at Monterey Bay Nutraceuticals, we started talking to marine and ocean experts at the Moss Landing Marine Laboratory and with others, such as the people involved with Virgin Oceanic, Richard Branson's deep sea microbial expeditions and research. Further we have been watching the work being done with the Turritopsis dohrnii jellyfish in Japan. This jellyfish is a living being that has the capability - at any stage of its development — to transform itself back to a polyp, the organism’s earliest stage of life, and thus escape death and achieve potential immortality. This turns one of the most fundamental laws of the natural world upside down which is the belief that you are born, and then you eventually die. Most exciting is that we have learned that during rejuvenation, this jellyfish undergoes cellular transdifferentiation, an unusual process by which one type of cell is converted into another — a nerve cell into a skin cell, for instance. This is amazingly similar to the work we’re seeing done with our partner laboratories and their findings in working with human stem cells.”

With only a few scientists in the world studying the jellyfish and too few dollars going to them, Vestiage hopes to help these scientist create breakthrough ingredients that it can translate into products for its premium and prestige anti-aging customers. Vestiage intends to establish a method for funding the scientists through a non-profit or other venture and by holding events that will benefit longevity and anti-aging research goals.

“Our goal as a company is, of course, to make money for our shareholders but that is not distinct and apart from also advancing the science of our industry and pushing funding in the right direction to make important discoveries for anti-aging. I believe we can do something here to radically change human longevity and the quality of our lives,” said Kimball. “The longevity research we’re doing is focused on a combination of Telomere lengthening, deep sea microbial and human stem cell research, and the work with our deep sea friend, the Benjamin Button Jellyfish, Turritopsis Dohrnii. Hopefully, as clinical results come in from these areas, we can apply new potential ingredients to functional anti-aging products and really rock the anti-aging world.”

Monterey Bay Nutraceuticals has concluded its research and development of three revolutionary products in conjunction with its partners Robinson Pharma and NutraGenesis. The first three products by Monterey Bay Nutraceuticals are “Calm and Collected”, a “mood leveling” and anti-stress soft gel, “Trim and Energized”, a weight management and sustained energy soft gel, and “Super Soft Skin!”, a “beauty from the inside-out” soft gel designed to enhance skin elasticity and protect the youthfulness of skin as well as relieve the symptoms of stress brought on by aging. Monterey Bay Nutraceuticals is currently talking to distributors for these three initial products and will begin taking orders this summer. Advance orders can be sent directly to garrett@vestiageinc.com. Monterey Bay Nutraceutical products can be seen online at http://www.montereybaynutra.com or can soon be found soon in your specialty grocery or independent health food and vitamin retailer.

About Vestiage, Inc
Vestiage is a publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine, and cutting edge botanically based sciences and ingredients to produce highly potent, elegantly formulated, effective products with clinically proven ingredients. Using high potency and novel ingredient combinations, Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com). Vestiage brands address the top “in demand” anti-aging consumer concerns. To learn more, visit the Company website, http://www.vestiageinc.com.

About NutraGenesis
NutraGenesis is one of the industry's leading providers of proprietary, branded nutraceutical ingredients. Our scientifically validated, bioactive, functional ingredients are designed to excel in the dietary supplement and food & beverage marketplaces. Merging advanced nutritional technology with exceptional marketing skills, we offer a superior portfolio of safe, effective ingredients that support health and wellness. For more information, go to http://www.nutragenesis.com.

About Robinson Pharma
Robinson Pharma is a leading manufacturer of products that support wellness and health. We are the most extensively certified manufacturer of nutraceutical and pharmaceutical products in America and are the largest capacity manufacturer of softgels in America. For more information, go to http://www.robinsonpharma.com.

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control. Copies of our SEC reports are available upon request from our investor relations department or may be obtained at the SEC's website (http://www.sec.gov).

Read the full story at http://www.prweb.com/releases/2013/4/prweb10608765.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Vestiage to Partner with Skincare By Alana
2. Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin
3. A New way to Battle Acne? NPR says “Cut the Carbs”: Probiotic Action Comments on the Recent News
4. Probiotic Action Comments on New Findings on Using Light Therapy to Fight Acne
5. Acne Treatment Brand, Probiotic Action, Comments on the Use of a Virus to Treat Acne
6. Probiotic Comments on Claims that Plant-Based Oils Are the Best Acne Treatments
7. Probiotic Action Comments on Huffington Post’s, Best Foods for Acne and offers Advice on Foods to Balance your Body
8. An article from Bloomberg.com discusses Ban on a Common Acne Treatment; Probiotic Action Comments On the product Ban
9. Can You Be Too Old for Acne? Probiotic Action comments on news from The Vitals Blog
10. Probiotic Action Comments on Acne Statistics by WebMD
11. Jennifer Aniston's People's Choice Awards Dress Worries Animal Welfare Advocates; Going Green News Site My Cleaning Products Comments It Was a Bad Pick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell ... RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
Breaking Biology Technology:
(Date:11/17/2016)... CITY OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it ... about using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer ... ... ... Setting ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):